Azizidoost Shirin, Ahmadzadeh Ahmad, Rahim Fakher, Shahjahani Mohammad, Seghatoleslami Mohammad, Saki Najmaldin
Health research institute, Research Center of Thalassemia &Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Tumour Biol. 2016 Feb;37(2):1493-503. doi: 10.1007/s13277-015-4557-x. Epub 2015 Dec 11.
Liver is the organ responsible for hematopoiesis during fetal life, which is also a target organ of metastasis for several cancers. In order to recognize the hepatic metastatic changes, obtain a better grasp of cancer prevention, treatment, and inhibition mode of hepatic metastasis progression, we investigate the changes and transformation of normal hepatic niche cells to metastatic niche ones in this review. On the other hand, since metastatic diseases alter the liver function, the changes in a number of cancers that metastasize to the liver have also been reviewed. Relevant English-language literature was searched and retrieved from PubMed (1994-2014) using the following keywords: hepatic stem cell niche, hepatic metastatic niche, chemokine, and microRNAs (miRNAs). Also, over 86 published studies were investigated, and bioinformatics analysis of differentially expressed miRNAs in hepatic cancer and metastasis was performed. Metastasis is developed in several stages with specific changes and mechanisms in each stage. Recognition of these changes would lead to detection of new biomarkers and clinical targets involved in specific stages of liver metastasis. Investigation of the hepatic stem cell niche, development of metastasis in liver tissue, as well as changes in chemokines and miRNAs in metastatic hepatic niche can significantly contribute to faster detection of liver metastasis progression.
肝脏是胎儿期负责造血的器官,也是多种癌症的转移靶器官。为了认识肝脏的转移变化,更好地掌握癌症预防、治疗以及抑制肝转移进展的模式,我们在本综述中研究正常肝脏微环境细胞向转移微环境细胞的变化与转变。另一方面,由于转移性疾病会改变肝功能,我们也综述了一些转移至肝脏的癌症的变化情况。使用以下关键词在PubMed(1994 - 2014年)中搜索并检索相关英文文献:肝干细胞微环境、肝转移微环境、趋化因子和微小RNA(miRNA)。此外,还研究了86篇以上已发表的研究,并对肝癌和转移中差异表达的miRNA进行了生物信息学分析。转移分几个阶段发展,每个阶段都有特定的变化和机制。认识这些变化将有助于发现肝转移特定阶段涉及的新生物标志物和临床靶点。对肝干细胞微环境、肝组织中转移的发展以及转移肝微环境中趋化因子和miRNA的变化进行研究,可显著有助于更快地检测肝转移进展。